Zobrazeno 1 - 10
of 363
pro vyhledávání: '"T2DM, Type 2 diabetes mellitus"'
Publikováno v:
Journal of Diabetology, Vol 13, Iss 2, Pp 139-144 (2022)
Introduction: There is a dearth of studies evaluating sexual dysfunction in women with Type 2 Diabetes Mellitus (T2DM), despite anecdotal evidence suggesting an association between glycemic control and female sexual health. Materials and Methods: An
Externí odkaz:
https://doaj.org/article/9c91b9dedbce41079f8298acd94b8023
Autor:
Kalliopi K. Gkouskou, Maria G. Grammatikopoulou, Evgenia Lazou, Despina Sanoudou, Dimitrios G. Goulis, Aristides G. Eliopoulos
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
Type 2 diabetes mellitus (T2DM) is a heterogeneous metabolic disorder of multifactorial etiology that includes genetic and dietary influences. By addressing the latter, medical nutrition therapy (MNT) contributes to the management of T2DM or pre-diab
Externí odkaz:
https://doaj.org/article/9944204cceba4085a80e140651576dae
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background Type 2 diabetes mellitus (T2DM) and hyperlipidemia are negatively related to bone regeneration. The aim of this study was to evaluate the effect of high-fat and high-glucose microenvironment on bone regeneration and to detect the
Externí odkaz:
https://doaj.org/article/684861e18f514a8da3b71a203668c6f7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Diana Luz Juárez-Flores, Mario Ezquerra, ïngrid Gonzàlez-Casacuberta, Aida Ormazabal, Constanza Morén, Eduardo Tolosa, Raquel Fucho, Mariona Guitart-Mampel, Mercedes Casado, Francesc Valldeoriola, Joan de la Torre-Lara, Esteban Muñoz, Ester Tobías, Yaroslau Compta, Francesc Josep García-García, Carmen García-Ruiz, Jose Carlos Fernandez-Checa, Maria José Martí, Josep Maria Grau, Francesc Cardellach, Rafael Artuch, Rubén Fernández-Santiago, Glòria Garrabou
Publikováno v:
Antioxidants, Vol 9, Iss 11, p 1063 (2020)
Idiopathic Parkinson’s disease (iPD) and type 2 diabetes mellitus (T2DM) are chronic, multisystemic, and degenerative diseases associated with aging, with eventual epidemiological co-morbidity and overlap in molecular basis. This study aims to expl
Externí odkaz:
https://doaj.org/article/16b6809826044832a91b3dac74fed192
Publikováno v:
Indian Heart Journal, Vol 73, Iss 5, Pp 605-611 (2021)
Indian Heart Journal
Indian Heart Journal
Objectives We evaluated the efficacy and safety of dapagliflozin, a SGLT2i along with ARNI in refractory HFrEF irrespective of their diabetic status. Methods We performed a retrospective analysis of 104 symptomatic patients of HFrEF despite of optima
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 4, Pp 743-752 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 4, Pp 743-752 (2021)
Objective To assess the extent to which the established age-related decline in cardiorespiratory fitness (CRF) is augmented in adult men with type 2 diabetes mellitus (T2DM). Participants and Methods This study used data from the Aerobics Center Long
Publikováno v:
AACE Clinical Case Reports
AACE Clinical Case Reports, Vol 8, Iss 1, Pp 30-33 (2022)
AACE Clinical Case Reports, Vol 8, Iss 1, Pp 30-33 (2022)
Introduction SGLT2 inhibitors are the newest class of oral anti-hyperglycemic agents that have been approved for the treatment of type 2 diabetes (T2DM). For many years, there have been significant developments in both the safety and efficacy of this
Autor:
Ana De Jesus-Acosta, Kacey Chae, Nestoras Mathioudakis, Ryan B. Fransman, Jordan Perlman, Christopher L. Wolfgang
Publikováno v:
AACE Clinical Case Reports
AACE Clinical Case Reports, Vol 7, Iss 6, Pp 379-382 (2021)
AACE Clinical Case Reports, Vol 7, Iss 6, Pp 379-382 (2021)
Objective We describe a rare case of profound subcutaneous insulin resistance (SIR) presumed due to a paraneoplastic process caused by pancreatic adenocarcinoma that improved with intravenous insulin and tumor resection. Methods An 80-year-old man wi